A news article today morning caught my eye.
Drug-maker Cipla and vaccine maker Serum have come together again, but this time to market flu vaccine Nasovac-S in India. Serum will develop and manufacture the vaccine, and Cipla will exclusively market it in India.
Yes ladies and gentlemen, you heard it first here on AshrafH.com
To read the original article including my analysis of the major players please go to India & the flu during the winter of 2014-15